West Family Investments Inc. Buys 1,120 Shares of Sanofi (NASDAQ:SNY)

West Family Investments Inc. increased its stake in shares of Sanofi (NASDAQ:SNY) by 18.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,339 shares of the company’s stock after buying an additional 1,120 shares during the quarter. West Family Investments Inc.’s holdings in Sanofi were worth $354,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of SNY. Abel Hall LLC boosted its position in Sanofi by 1.8% in the fourth quarter. Abel Hall LLC now owns 10,990 shares of the company’s stock worth $530,000 after purchasing an additional 194 shares during the last quarter. Angeles Investment Advisors LLC boosted its position in Sanofi by 1.9% in the third quarter. Angeles Investment Advisors LLC now owns 11,323 shares of the company’s stock worth $653,000 after purchasing an additional 210 shares during the last quarter. Keudell Morrison Wealth Management boosted its position in Sanofi by 1.7% in the fourth quarter. Keudell Morrison Wealth Management now owns 12,928 shares of the company’s stock worth $624,000 after purchasing an additional 217 shares during the last quarter. Bailard Inc. boosted its position in Sanofi by 1.4% in the fourth quarter. Bailard Inc. now owns 16,359 shares of the company’s stock worth $789,000 after purchasing an additional 220 shares during the last quarter. Finally, Old Port Advisors boosted its position in Sanofi by 0.6% in the fourth quarter. Old Port Advisors now owns 36,704 shares of the company’s stock worth $1,770,000 after purchasing an additional 232 shares during the last quarter. Institutional investors own 14.04% of the company’s stock.

Sanofi Stock Down 0.3 %

SNY stock opened at $59.25 on Friday. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.14 and a current ratio of 1.46. The company has a market capitalization of $150.37 billion, a price-to-earnings ratio of 23.80, a PEG ratio of 1.01 and a beta of 0.58. Sanofi has a fifty-two week low of $45.22 and a fifty-two week high of $59.72. The stock has a fifty day moving average of $52.44 and a 200-day moving average of $52.73.

Sanofi (NASDAQ:SNY) last posted its quarterly earnings results on Thursday, January 30th. The company reported $0.70 earnings per share for the quarter, hitting the consensus estimate of $0.70. Sanofi had a return on equity of 25.61% and a net margin of 12.77%. As a group, equities research analysts predict that Sanofi will post 4.36 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have weighed in on SNY. StockNews.com cut Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. Sanford C. Bernstein upgraded Sanofi to a “strong-buy” rating in a research note on Thursday, January 30th. Finally, Deutsche Bank Aktiengesellschaft upgraded Sanofi from a “sell” rating to a “hold” rating in a research note on Thursday, January 30th. Two investment analysts have rated the stock with a hold rating, one has given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $60.00.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.